For endorsement at the 21st AHWP Meeting-PROPOSED FINAL document on "Guidelines for Adverse Event Reporting of Percutaneous Coronary Intervention (PCI) Devices for the Medical Device Manufacturer or Its Authorized Representative"


                                          
 

After consolidating the comments received from AHWP members by 18 Nov 2016, the PROPOSED document on "Guidelines for Adverse Event Reporting of Percutaneous Coronary Intervention (PCI) Devices for the Medical Device Manufacturer or Its Authorized Representative" developed by AHWP WG4 has become the captured PROPOSED FINAL document, for the endorsement at the 21st AHWP Meeting in Cebu.
 

Download file: Guidelines for Adverse Event Reporting of Percutaneous Coronary Intervention (PCI) Devices1for the Medical Device Manufacturer or Its Authorized Representative.pdf